Featured Story | By Nick Paul Taylor Bristol Myers Squibb and Nektar have read the last rites to their huge, failed cancer collaboration. With two more late-stage trials failing, the partners have ended clinical development of a combination they once saw as the future of immuno-oncology. read more |
| |
|---|
|
Top Stories By Max Bayer TG Therapeutics is heading back to the drawing board after new data showed its cancer drug had an elevated risk of death, plucking Ukoniq off the market for the two indications it won accelerated approval for, in addition to withdrawing an approval request for a combo med. read more By Gabrielle Masson Some biotechs are building as others crumble, with several industry players–including AstraZeneca's Alexion and Arvinas involved in plans for a new 10-floor tower built for burgeoning biotechs. read more By Gabrielle Masson The FDA is prioritizing diversity among clinical trial participants in the U.S., with new draft guidance aimed at boosting enrollment of participants from underrepresented racial and ethnic populations. read more By James Waldron Inflammatory-disease-focused Evelo Biosciences has hit the brakes on one of its atopic dermatitis treatments after a phase 1 trial failed to demonstrate clinical benefit. read more By Nick Paul Taylor The Netherlands is pumping 325 million euros ($351 million) into preclinical cancer drug development. Using the cash, the Dutch National Growth Fund aims to provide specialist capabilities that help biotechs speed up development of oncology candidates. read more By Kevin Dunleavy A document from the World Health Organization shows that low-income countries have declined tens of millions of doses of AstraZeneca's COVID-19 vaccine, Reuters reports. The countries are turning away from the shot because of its shorter shelf life and because other vaccines have become more plentiful. read more By Conor Hale They include methods to preserve fragile human tissues as well as a way to more easily access frozen samples. read more By Robert King A new survey of registered nurses shows that incidents of workplace violence have spiked as well as increases in burnout at hospitals across the country. read more By Natalie Missakian Pro golfer Jason Day shares golf tips and wisdom about biomarker testing and caring for a loved one with lung cancer in a new AstraZeneca video series, which includes a lineup of celebrity guests. read more By Max Bayer Pfizer is bringing on former CVS exec David Denton as CFO, the same role he held when he oversaw the major retailer's acquisition of insurance giant Aetna. Jorge Gomez is joining Moderna as CFO after David Meline retires for a second time. Editas has a new leader, naming Gilmore O’Neill as its new CEO while the CMO position remains empty. read more By Angus Liu Daiichi Sankyo lost to Seagen in the first found of a patent battle. A U.S. gene therapy delivery CDMO will build a $500 million campus in China. Legend Biotech is the latest Chinese firm flagged by U.S. securities authorities for audit law violations. And more. read more Resources Sponsored By: H1 More than 570 clinical trials in Ukraine have been disrupted. Unanticipated disruptions to medical testing and clinical trials impede progress toward new breakthroughs and new therapies that millions of patients around the world hang their hope on. What role do rescue sites play? Sponsored by: Nethealth Net Health, experts in wound care and dermatology clinical trials, have a new eBook: 5 Rules to Enhance Clinical Trials in 2022, find out how to recruit the right participants, connect patients and researchers with technology, manage costs and more. Sponsored by: United Cargo The United Cargo team has made a commitment to pharmaceutical and medical partners that we are equipped to support their vaccine transportation needs safely and effectively across our expansive global and domestic network. The safety and security of these commodities is our priority, and we are proud to be a trusted partner in these efforts. Download infographic now. Presented By: Springer Nature The journey of drug development in 2021 delivered to your inbox: top 10 AdisInsight drug profiles viewed, new drug profiles released, overview of drug launches, key deals, research trends in 2021 and much more (free of charge). Sponsored by: Blue Matter, strategic consultants in the life sciences What’s in store for the oncology market in 2022 and beyond? This paper looks at 5 trends driving the market. Sponsored by: Thermo Fisher Scientific Learn how to position quality as a central component within your raw material sourcing strategies for the chemicals used throughout your workflows. Download the free whitepaper from Thermo Fisher Scientific. Cancer Progress 2022: Hear from Leading Oncology Innovators May 10-12, 2022 | Virtual Fierce Promotional Review Committee Compliance and Best Practices Summit April 12-14, 2022 | New Brunswick, NJ Accelerating Immuno-Oncology and Oncology Drug Development Using Humanized Mice Live & Recorded on: Thursday, April 21, 2022 | 12pm ET / 9am PT Fierce Trial Master File Summit May 2-4, 2022 | New Orleans, LA & Streaming Live Fierce Digital Pharma Engage June 14-15, 2022 | Huntington Beach, CA Fierce Digital Pharma Innovation Week June 21-23, 2022 | Virtual Event Promotional Review Committee Compliance and Best Practices Summit West (PRC West) September 2022 | San Diego, CA Fierce New Product Planning Summit September 20-22, 2022 | Boston, MA Fierce Digital Pharma East October 18-20, 2022 | Philadelphia, PA & October 25-28, 2022 | Virtual Event Fierce Pharma Marketing Awards October 19, 2022 | Philadelphia, PA Fierce Biotech Cell & Gene Therapy Forum October 19, 2022 | Virtual Event Fierce Pharma Meeting Professionals Summit November 2-3, 2022 | Atlantic City, NJ Fierce European Trial Master File Summit November 14-16, 2022 | London, UK Fierce Launch Readiness for Medical Affairs & Communications Teams Summit November 30-December 1, 2022 | Virtual Event Fierce JPM Week 2023 January 2023 | San Francisco, CA & Virtual | 
